Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure
2021 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure
Ambrosy, A. P.; von Haehling, S.; Kalra, P. R.; Court, E.; Bhandari, S.; McDonagh, T. & Cleland, J. G. (2021)
The American Journal of Cardiology, 152 pp. 138-145. DOI: https://doi.org/10.1016/j.amjcard.2021.04.042
